Palo Alto Health Sciences, which has developed a mobile-enabled breathing system for people with panic disorder, raised $1.97 million in the second tranche of a $5 million round. The investment was led by Aphelion Capital with participation from other angel investors. Palo Alto Health Sciences has raised $7.5 million to date.
The company’s FDA-cleared offering, called the Freespira Breathing...
